Trials / Terminated
TerminatedNCT02553239
CoolLoop Paroxysmal Atrial Fibrillation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- afreeze GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation evaluates the safety of cryoablation (sclerotherapy of muscle tissue of the heart by freezing) in paroxysmal atrial fibrillation with the newly developed CoolLoop® cryoablation catheter. A further aim of the investigation is the evaluation of the efficacy and average duration of the applied procedure.
Conditions
- Atrial Fibrillation (Paroxysmal)
- Arrhythmias, Cardiac
- Cardiovascular Diseases
- Heart Diseases
- Pathologic Processes
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CoolLoop® | Cryoablation of Atrial Fibrillation Using the CoolLoop Cryoablation System |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2019-02-14
- Completion
- 2019-02-14
- First posted
- 2015-09-17
- Last updated
- 2019-03-15
Locations
4 sites across 3 countries: Austria, Germany, Switzerland
Source: ClinicalTrials.gov record NCT02553239. Inclusion in this directory is not an endorsement.